^^'•incioai investigatof/Program Director /Last, tirst. midcllei 
BIOGRAPHICAL SKETCH 
Give ine loiiowmq miormation for tne Key oersonnei ana consultants ana coiiaoorators. Begin with the onncioai 
■nvestigator/orogram airector. Photocooy this page tor eacn oerson. 
NAME POSITION TITLE 
Seeger, Robert C. MD Principal Investigator 
EDUCATION (Begin witn baccalaureate or other inivai professional education, sucn as nursing, ana include Dostaoaoral training.) 
INSTITUTION AND LOCATION 
DEGREE 
YEAR 
CONFERRED 
FIELD OF STUDY 
Willamette University, Salem, OR 
I BA 
1962 
Chemistry 
Univ. of Oregon Med. School, Portland, OR 
1 MS, MD 
1966 
Anatomy; Medicine 
Natl. Inst, of Health, Bethesda, MD 
i Clin Assoc 
1968 
Cellular Immunology 
Univ. College London, London, England 
i Postdoc. 
1 Fellow 
1972 

Tumor Immunology 
RESEARCH AND PROFESSIONAL EXPERIENCE; Concluding with present position, list, in chronological order, previous employment, expenence. and 
honors. Key personnel include the principal investigator and any other individuals wno partiapate in the scientific development or execution of the project 
Key personnel typically will include all individuals with doctoral or other professional degrees, but in some protects will include individuals at the masters or i 
oaccaiaureate level provided they contnoute m a suDstantive way to the scientific aeveiopment or execution of the protect. Include present membership on 
any Federal Government public advisory comminee. List, in chronological order, the titles, all authors, and complete references to all publications dunng tne 
oast three years and to representative earner publications peninent to this application. DO NOT EXCEED TWO PAGES. 
1966-1968 
1974-1977 
1977-1981 
1981-1983 
1983-1989 
1985- 1989 
1986- 1989 
1989-present 
Pediatric Internship and Residency, University of Minnesota Medical School, 
Minneapolis, MN 
Assistant Professor, Division of Immunology and Allergy, Department of Pediatrics, 
UCLA School of Medicine, Los Angeles, CA 
Associate Professor, Division of Immunology and Allergy, Department of Pediatrics, 
UCLA School of Medicine, Los Angeles, CA 
Associate Professor and Chief, Division of Cancer Immunology and Biology, 
Department of Pediatrics, UCLA School of Medicine, Los Angeles, CA 
Professor and Chief, Division of Cancer Immunology and Biology, Department of 
Pediatrics, UCLA School of Medicine, Los Angeles, CA 
Vice Chairman for Academic Affairs, Department of Pediatrics, UCLA School of 
Medicine, Los Angeles, CA 
Director for Clinical Research, Jonsson Comprehensive Cancer Center, UCLA School 
of Medicine, Los Angeles, CA 
Professor and Deputy Division Head for Research, Division of Hematology-Oncology, 
Department of Pediatrics, Childrens Hospital Los Angeles/USC School of Medicine, 
Los Angeles, CA 
HONORS: Special Post Doctoral Fellow, National Cancer Institute, 1972-1974 . ( 
Research Careeh Development Award, National Cancer Institute, 1975-1980 j 
I 1 
SELECTED PUBLICATIONS: (from a total of 112) j ; 
Seeger RC, Rayner SA, Banerjee A, Chung H, Laug WE, Neustein HB, Benedict WF. Morphology, growth, i , 
chromosomal pattern, and fibrinolytic activity of two new human neuroblastoma cell lines. Cancer Res ■ , 
37:1364-71, 1977. 
West GJ, Uki J, Herschman HR, Seeger RC. Adrenergic, cholinergic, and inactive human neuroblastoma cell 
lines with action potential Na+ ionophore. Cancer Res 31:1312-6, 1977. 
Seeger RC, Rosenblatt HM, Imai K, Ferrone S. Common antigenic determinants on human melanoma, . 
glioma, neuroblastoma, and sarcoma cells defined with monoclonal antibodies. Cancer Res 41:2714-7, 1981. , 
Seeger RC. Danon YL, Hoover F, Rayner SA. Definition of a Thy- 1 determinant on human neuroblastoma, 
glioma, sarcoma, and teratoma cells with a monoclonal antibody. J Immunol 128:983-9, 1982. 
Sidell N, Altman A, Haussler MR, Seeger RC. Effects of retinoic acid on the growth and phenotypic 
expression of several human neuroblasto ma cell lines. Exp Cell Res 148:21-30, 1983. 
Pa9«R>#(?S?nbinant DNA Research, Volume 19 
NvibM’omjn consecutively at tne oonom tnrougnout tnt aooncation. Oo not use suflixet sucn 
